Targeting Ccl12 may be an antifibrotic strategy, as the Ccl12-Ccr2 axis drives fibrocyte influx and fibroproliferation in mouse fibrosis models, with Ccl12 neutralization being more effective than Ccl2 in protecting from FITC-induced fibrosis [169]. This evidence concerns the gene CCR2 and fibrosis.